NCT01378221

Brief Summary

Advanced age is associated with an increase in postoperative morbidity and mortality in cardiac surgery patients. In detail, compared with younger patients those aged 75 years and older have significantly higher rates of in-hospital mortality, cerebrovascular events, pneumonia, and dialysis. In addition, older cardiac surgery patients have longer mechanical ventilation times. Vitamin D exerts several beneficial effects on the cardiovascular system. Moreover, it has immuno-modulatory and anti-inflammatory properties. The hormonal form of vitamin D, 1,25-dihydroxyvitamin D, is an independent predictor of mid-term mortality in cardiac transplant recipients. 1,25-dihydroxyvitamin D also predicts mid-term and long-term mortality in patients with a high risk for cardiovascular disease. Mild renal impairment, insufficient vitamin D levels, and secondary hyperparathyroidism are common in frail elderly individuals. The present study aimed to investigate whether cardiac surgery exerts age-dependent effects on calciotropic hormones, components of the immune system, and inflammatory processes.It is hypothesized that (i) baseline 1,25-dihydroxyvitamin D levels are lower in patients \<= 75 years of age compared to younger patients, (ii) cardiac surgery results in a transient decrease in circulating 1,25-dihydroxyvitamin D, and (iii) that the decrease in 1,25-dihydroxyvitamin D is probably more pronounced in older than in younger cardiac surgery patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 22, 2011

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

January 30, 2014

Completed
Last Updated

January 30, 2014

Status Verified

December 1, 2013

Enrollment Period

1.4 years

First QC Date

June 20, 2011

Results QC Date

December 11, 2013

Last Update Submit

December 11, 2013

Conditions

Keywords

vitamin Dcardiac surgeryinflammationimmune systemage

Outcome Measures

Primary Outcomes (1)

  • Peri- and Postoperative Time Course of Circulating 1,25-dihydroxyvitamin D in the First Postoperative Month in Cardiac Surgery Patients

    change from baseline within 1 month after cardiac surgery

Study Arms (2)

Group 1

cardiac surgery patients age 65 years and less

Group 2

cardiac surgery patients aged 75 years and over

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

elective cardiac surgery patients receiving isolated coronary artery bypass grafting or combined coronary artery bypass grafting and heart valve surgery

You may qualify if:

  • age: \<= 65 years and \>= 75 years
  • first elective cardiac surgery (bypass or combined bypass and heart valve surgery)
  • written informed consent

You may not qualify if:

  • emergency cardiac intervention
  • primary hyperparathyreoidism
  • primary and secondary hypoparathyreoidism
  • daily vitamin D supplementation \> 10 micrograms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heart Center North Rhine-Westphalia

Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany

Location

Related Publications (1)

  • Borgermann J, Lazouski K, Kuhn J, Dreier J, Schmidt M, Gilis-Januszewski T, Knabbe C, Gummert JF, Zittermann A. 1,25-Dihydroxyvitamin D fluctuations in cardiac surgery are related to age and clinical outcome*. Crit Care Med. 2012 Jul;40(7):2073-81. doi: 10.1097/CCM.0b013e31824e8c42.

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Armin Zittermann
Organization
Heart and Diabetes Center North Rhine-Westphalia, Germany

Study Officials

  • Jochen Börgermann, MD

    Heart Center NRW, Ruhr University Bochum, 32545 Bad Oeynhausen, Germany

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2011

First Posted

June 22, 2011

Study Start

September 1, 2009

Primary Completion

February 1, 2011

Study Completion

May 1, 2011

Last Updated

January 30, 2014

Results First Posted

January 30, 2014

Record last verified: 2013-12

Locations